MiRNA-20A Upregulates TAK1 and Increases Proliferation in Osteosarcoma Cells
Open Access
- 12 January 2018
- journal article
- research article
- Published by Taylor & Francis in Future Oncology
- Vol. 14 (5) , 461-469
Abstract
Aim: The aim of this study is to explore the function of miR-20a in osteosarcoma. Materials & methods: miR-20a expression was measured by real-time PCR. miR-20a mimics, inhibitor and scramble siRNA were transfected into osteosarcoma cells to observe effects on colony formation and tumor growth. Moreover, relationships of miR-20a with TAK1 were investigated by western blot and luciferase activity. Results: We found that miR-20a was downregulated in osteosarcoma, and overexpression of miR-20a reduced colony formation and tumor growth. Furthermore, the data revealed that the function of miR-20a was probably exerted via targeting the TAK1 expression. Overexpression of miR-20a sensitizes the osteosarcoma cells to chemotherapeutic drugs. Conclusion: Our data identify the role of miR-20a in osteosarcoma growth, indicating its potential application in chemotherapy.Keywords
This publication has 22 references indexed in Scilit:
- Identification and validation of microRNAs directly regulating the UDP-glucuronosyltransferase 1A subfamily enzymes by a functional genomics approachBiochemical Pharmacology, 2017
- Serum MicroRNAs Related with Chemoradiotherapy Resistance in Advanced-Stage Cervical Squamous Cell CarcinomaTranslational Oncology, 2017
- The Molecular Genetic Expression as a Novel Biomarker in the Evaluation and Monitoring of Patients With Osteosarcoma-Subtype Bone Cancer DiseaseBiochemical Genetics, 2017
- Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized DiseaseCurrent Treatment Options in Oncology, 2017
- Metabolic Reprogramming of Cancer-Associated Fibroblasts by IDH3α DownregulationCell Reports, 2015
- Hypoxia‐induced miR‐497 decreases glioma cell sensitivity to TMZ by inhibiting apoptosisFEBS Letters, 2014
- Hypoxia-induced miR-424 decreases tumor sensitivity to chemotherapy by inhibiting apoptosisCell Death & Disease, 2014
- Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic diseaseMolecular Immunology, 2014
- miR‐181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathwayFEBS Letters, 2014
- BCR-ABL Gene Expression Is Required for Its Mutations in a Novel KCL-22 Cell Culture Model for Acquired Resistance of Chronic Myelogenous LeukemiaJournal of Biological Chemistry, 2010